跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 69,167 条关于
“tissue kallikrein-1”
全部
69,167
临床试验
42,563
药物
7,364
机构
1,412
资讯
17,828
去年
First Clinical Trial of DM199 Launched to Combat Preeclampsia
6个月前
DiaMedica Receives Health Canada Approval for Phase II Preeclampsia Trial of DM199
去年
DM199's Novel Mechanism for Acute Stroke Treatment Detailed in Stroke Journal Publication
去年
DiaMedica Receives SAHPRA Approval to Commence Phase II Preeclampsia Trial with DM199
去年
DiaMedica Therapeutics Secures $30.1 Million to Advance DM199 for Preeclampsia and Fetal Growth Restriction
去年
Acute Ischemic Stroke Pipeline Shows Promise with 25+ Therapies in Development and Recent Clinical Breakthroughs
上个月
DiaMedica's DM199 (Rinvecalinase Alfa) Advances in Preeclampsia and Stroke: Phase 2 Data, Regulatory Milestones, and Market Outlook
去年
Triveni Bio Initiates First-in-Human Trial of TRIV-509 for Atopic Dermatitis, Targeting Novel Kallikrein Pathway
8天前
Immutep Refocuses Eftilagimod Alfa Development on HNSCC With CPS <1 and Neoadjuvant Soft Tissue Sarcoma
去年
Rezolute's Oral Plasma Kallikrein Inhibitor RZ-402 Shows Promise in Phase IIa Trial for Diabetic Macular Edema
第 1 页,共 1783 页
上一页
下一页